HomeEVGN • NASDAQ
add
Evogene Ltd
Nakaraang pagsara
$1.00
Sakop ng araw
$0.99 - $1.01
Sakop ng taon
$0.99 - $8.90
Market cap
6.45M USD
Average na Volume
20.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.61M | 178.72% |
Gastos sa pagpapatakbo | 5.92M | -24.14% |
Net na kita | 427.00K | 106.47% |
Net profit margin | 26.51 | 102.32% |
Kita sa bawat share | 0.06 | 104.62% |
EBITDA | -4.47M | 35.76% |
Aktuwal na % ng binabayarang buwis | 350.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 15.31M | -50.71% |
Kabuuang asset | 39.86M | -21.99% |
Kabuuang sagutin | 25.03M | 11.64% |
Kabuuang equity | 14.84M | — |
Natitirang share | 6.51M | — |
Presyo para makapag-book | -4.52 | — |
Return on assets | -31.68% | — |
Return on capital | -83.71% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 427.00K | 106.47% |
Cash mula sa mga operasyon | -5.21M | 12.12% |
Cash mula sa pag-invest | 8.76M | 1,594.54% |
Cash mula sa financing | 440.00K | 399.32% |
Net change in cash | 3.98M | 160.74% |
Malayang cash flow | -9.20M | -148.92% |
Tungkol
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Itinatag
2002
Website
Mga Empleyado
117
